480 related articles for article (PubMed ID: 36065108)
1. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
[No Abstract] [Full Text] [Related]
2. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.
Gorochov G; Ropers J; Launay O; Dorgham K; da Mata-Jardin O; Lebbah S; Durier C; Bauer R; Radenne A; Desaint C; Vieillard LV; Rekacewicz C; Lachatre M; Parfait B; Batteux F; Hupé P; Ninove L; Lefebvre M; Conrad A; Dussol B; Maakaroun-Vermesse Z; Melica G; Nicolas JF; Verdon R; Kiladjian JJ; Loubet P; Schmidt-Mutter C; Dualé C; Ansart S; Botelho-Nevers E; Lelièvre JD; de Lamballerie X; Kieny MP; Tartour E; Paul S
JAMA Netw Open; 2024 Apr; 7(4):e248051. PubMed ID: 38652471
[TBL] [Abstract][Full Text] [Related]
3. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
4. Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.
Thomas SN; Karger AB; Altawallbeh G; Nelson KM; Jacobs DR; Gorlin J; Barcelo H; Thyagarajan B
Sci Rep; 2022 May; 12(1):8890. PubMed ID: 35614113
[TBL] [Abstract][Full Text] [Related]
5. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
[TBL] [Abstract][Full Text] [Related]
6. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Faustini SE; Jossi SE; Perez-Toledo M; Shields AM; Allen JD; Watanabe Y; Newby ML; Cook A; Willcox CR; Salim M; Goodall M; Heaney JL; Marcial-Juarez E; Morley GL; Torlinska B; Wraith DC; Veenith TV; Harding S; Jolles S; Ponsford MJ; Plant T; Huissoon A; O'Shea MK; Willcox BE; Drayson MT; Crispin M; Cunningham AF; Richter AG
Immunology; 2021 Sep; 164(1):135-147. PubMed ID: 33932228
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
Costantini VP; Nguyen K; Lyski Z; Novosad S; Bardossy AC; Lyons AK; Gable P; Kutty PK; Lutgring JD; Brunton A; Thornburg NJ; Brown AC; McDonald LC; Messer W; Vinjé J
J Immunol; 2022 Mar; 208(6):1500-1508. PubMed ID: 35228262
[TBL] [Abstract][Full Text] [Related]
9. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C; Nilsson J; Zurbuchen Y; Valaperti A; Schreiner J; Wolfensberger A; Raeber ME; Adamo S; Weigang S; Emmenegger M; Hasler S; Bosshard PP; De Cecco E; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Zinkernagel AS; Schaer DJ; Aguzzi A; Kochs G; Held U; Probst-Müller E; Rampini SK; Boyman O
J Allergy Clin Immunol; 2021 Feb; 147(2):545-557.e9. PubMed ID: 33221383
[TBL] [Abstract][Full Text] [Related]
10. Human IgG and IgA responses to COVID-19 mRNA vaccines.
Wisnewski AV; Campillo Luna J; Redlich CA
PLoS One; 2021; 16(6):e0249499. PubMed ID: 34133415
[TBL] [Abstract][Full Text] [Related]
11. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
Front Immunol; 2021; 12():786554. PubMed ID: 35003104
[TBL] [Abstract][Full Text] [Related]
12. Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
Ota K; Sakai H; Sasaki D; Mitsumoto-Kaseida F; Sakamoto K; Kosai K; Hasegawa H; Takazono T; Izumikawa K; Mukae H; Tun MMN; Morita K; Yanagihara K
Virus Res; 2024 Jan; 339():199294. PubMed ID: 38056502
[TBL] [Abstract][Full Text] [Related]
13. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
14. The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
Chan RWY; Liu S; Cheung JY; Tsun JGS; Chan KC; Chan KYY; Fung GPG; Li AM; Lam HS
Front Immunol; 2021; 12():744887. PubMed ID: 34712232
[TBL] [Abstract][Full Text] [Related]
15. Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
Alkharaan H; Bayati S; Hellström C; Aleman S; Olsson A; Lindahl K; Bogdanovic G; Healy K; Tsilingaridis G; De Palma P; Hober S; Månberg A; Nilsson P; Pin E; Sällberg Chen M
J Infect Dis; 2021 Aug; 224(3):407-414. PubMed ID: 33978762
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
Sano K; Bhavsar D; Singh G; Floda D; Srivastava K; Gleason C; ; Carreño JM; Simon V; Krammer F
Nat Commun; 2022 Sep; 13(1):5135. PubMed ID: 36050304
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.
Pisanic N; Randad PR; Kruczynski K; Manabe YC; Thomas DL; Pekosz A; Klein SL; Betenbaugh MJ; Clarke WA; Laeyendecker O; Caturegli PP; Larman HB; Detrick B; Fairley JK; Sherman AC; Rouphael N; Edupuganti S; Granger DA; Granger SW; Collins MH; Heaney CD
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33067270
[TBL] [Abstract][Full Text] [Related]
18. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
[TBL] [Abstract][Full Text] [Related]
19. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.
Tsukinoki K; Yamamoto T; Handa K; Iwamiya M; Saruta J; Ino S; Sakurai T
PLoS One; 2021; 16(11):e0249979. PubMed ID: 34813596
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
